Reimagining the infrastructure of cancer care
Transforming possibilities into results
Featured products & solutions
Clinicians, researchers, and regulators rely on Flatiron technology and evidence to learn faster and power smarter care for every patient.
Achieve your oncology real-world evidence goals faster and more efficiently
Generate robust evidence and insights by partnering with Flatiron's expert team of clinicians, scientists, and health data analysts.
See how— Hear from our customers
Fit-for-purpose RWE solutions
Flatiron was chosen because it’s fit for purpose. You have the right population and good sample size with data for the endpoint, which is overall response rate. A key learning is you need to choose a database with good quality.
— By the numbers
3.5 million+
3.5 million+ patient records de-identified and available for research
Discover a faster, more efficient path to clean study data
One of the industry's first EHR-to-EDC connectors, Flatiron Clinical Pipe™ helps create a new trial experience.
See how— Hear from our customers
Transfer trial data faster
Working with partners like Flatiron and technology like [Flatiron] Clinical Pipe and Flatiron Vessel has been an excellent opportunity for us to really build processes and systems around the technology that is available today and get those technologies to work together.
— By the numbers
85 sites and counting
Flatiron Clinical Pipe™ is live at 85 sites and counting
Unleash precision oncology with our customizable clinical decision support platform
Improve the patient experience, streamline operations, and increase revenue with instinctive workflows, up-to-date treatment guidelines, and actionable data.
See how— Hear from our customers
Expand insights at the point of care
Flatiron Assist is a decision support tool that helps us choose and find the right regimens for our patients, stay within NCCN guidelines, and the treatment plans are very robust and customizable.
— By the numbers
44% reduction
44% reduction in the number of unique regimens ordered across cancer centers using Flatiron Assist™
Solving problems for teams across the oncology ecosystem
How we partner
Transforming cancer care takes all of us. Our vision is to build a world where technology and science close the gap between care and research.
Academic Medical Centers
Enable quality care by providing evidence-based treatment options to clinicians and run more efficient clinical research by surfacing trial-eligible patients directly in the EHR. Once enrolled, digitally transfer relevant trial data from the EHR to downstream systems.
HEOR & RWE Teams
Design and execute real-world studies including comparative effectiveness, modeling long-term survival, and analyzing treatment patterns to provide insights into a treatment's long-term effectiveness as well as support market access and reimbursement decisions.
Research & Early Development Teams
Quicken drug discovery and development by linking genomics data with clinical outcomes to help assess unmet need, generate hypotheses about biomarker resistance alterations and co-alterations, and inform decision-making.
how we partner
Clinical Operations Teams
Accelerate clinical research timelines, increase trial participant representativeness, and execute trials more efficiently to get your treatment to market sooner.
Regulatory Affairs Teams
Leverage Flatiron's extensive experience with regulatory-grade real-world data to develop regulatory strategies, prepare evidence packages for approval and post-market requirements, and lead regulatory engagement.
how we partner
Community Oncology Practices
Deliver quality patient care with a cancer-specific EHR and surface evidence-based treatment options. For practices that support research, save time and gain accuracy through data-backed identification of eligible trial patients in the EHR and digitally transfer relevant study data seamlessly between the EHR and EDC.
Market Access Teams
Demonstrate a cancer drug's value to payers and Health Technology Assessment (HTA) bodies to accelerate access to life-extending cancer treatments worldwide and ensure reimbursement and optimal pricing.
Pharmacovigilance & Epidemiology Teams
Monitor and assess the safety of cancer drugs, leveraging retrospective and prospective real-world studies to identify adverse events, detect safety signals, and provide insights into the long-term safety profile of cancer drugs beyond clinical trials.
how we partner
Contract Research Organizations
Optimize clinical trials with our novel, interoperable technology. Flatiron's products provide CROs with a streamlined, technology-driven approach to accelerate trial timelines, make data-backed decisions, and create efficiencies, giving you more confidence in trial success.
Clinical Development Teams
Utilize deep real-world data to assess the impact of inclusion/exclusion criteria and enable adjustments based on diversity goals and enrollment timelines through tailored protocol analyses that include insights on patient characteristics and expected outcomes.
Portfolio Strategy and Commercial Teams
Generate fast insights to identify portfolio gaps and opportunities, refine your commercial strategy and provide real-time line of sight into the launch performance and uptake with tailored RWE solutions.
how we partner
Medical Affairs Teams
Leverage Flatiron's RWE solutions to generate insights for the scientific community, regulatory agencies, healthcare professionals, and the broader market to ensure that new drugs are developed, communicated, and utilized effectively and ethically.
how we partner
New and noteworthy
featured news and insights
Explore the latest insights, research, and stories from Flatiron’s global team.
- Read more
Advancing equity in cancer care: Unveiling insights from the 2023 Real-World Data Impact Award
In its fourth year, the Real-World Data Impact Award, jointly presented by the American Cancer Society and Flatiron Health, offers researchers $75,000, access to one of Flatiron’s 20+ EDMs, and the support of Flatiron’s and the American Cancer Society’s clinical and methodological experts to answering pressing, clinically-relevant questions focused on inequities in cancer care.
- Read more
Caris Life Sciences and Flatiron Health Partner to Create Transformational Real-World Data Offering
The combined power from Caris’ DNA, RNA and imaging data with Flatiron’s world-classclinical data establishes a powerful multimodal dataset to drive next-gen therapeutic development and advance patient care.
- Read more
Scaling real-world data curation through machine learning and large language models
Learn about Flatiron’s latest discoveries and key learnings in applying machine learning (ML) and large language models (LLM) to unlock insights on large patient populations. Technology is fundamental to Flatiron’s mission of learning from the experience of every person with cancer. In particular, machine learning is critical to understanding the experience of people with cancer at scale. As cancer care becomes increasingly targeted, expanding the number of patients that we can learn from allows us to deliver rigorous insights about ever narrower populations with specific characteristics and experiences. These populations — whether defined by rare biomarkers, distinctive histologies, or atypical patterns of treatment — are increasingly the locus of breakthroughs in cancer care. While clinical expertise forms the core of our real world data curation efforts, technology allows that expertise to scale.
- Read more
Clearview Cancer Institute achieves high concordance with NCCN Guidelines® using Flatiron Assist™
By choosing a clinical decision platform that surfaces the most current NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Clearview Cancer Institute (CCI) drove concordance with evidence-based guidelines and achieved clinical, financial, and operational goals.